Oramed Pharmaceuticals Inc. (TLV:ORMP)
Israel
· Delayed Price · Currency is ILS · Price in ILA 817.00
-15.40 (-1.85%)
Feb 20, 2025, 5:24 PM IDT
Oramed Pharmaceuticals Market Cap
Oramed Pharmaceuticals has a market cap or net worth of 308.94 million as of February 21, 2025. Its market cap has decreased by -25.85% in one year.
Market Cap
308.94M
Enterprise Value
-202.34M
Revenue
n/a
Ranking
n/a
PE Ratio
18.61
Stock Price
817.00
Market Cap Chart
Since March 19, 2004, Oramed Pharmaceuticals's market cap has increased from 2.37M to 308.94M, an increase of 12,928.11%. That is a compound annual growth rate of 26.18%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 69.16B |
| Danel (Adir Yeoshua) | 2.53B |
| Kamada | 1.57B |
| Bait Bakfar | 1.09B |
| Novolog (Pharm-Up 1966) | 907.03M |
| Ilex Medical | 800.59M |
| BrainsWay | 762.81M |
| SofWave Medical | 597.96M |